WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Implantable infusion device    

Custom CD of patents similar to US5180365 : Implantable infusion device - $19.95
United States Patent5180365   
Link to this pagehttp://www.wikipatents.com/5180365.html
Inventor(s)Ensminger; William D. (2770 Parkridge Dr., Ann Arbor, MI 48103); Knol; James A. (1059 Hasper, Ann Arbor, MI 48103); Andrews; James C. (3568 River Pines, Ann Arbor, MI 48103)
AbstractAn infusion port designed for the introduction of a catheter for fluid infusion or removal or other flexible filaments within a patient. The infusion port is buried subcutaneously and accessed using a needle which introduces the filament. The infusion port has means to prevent the introducing needle from being inserted past a certain point within the port whereas the introduced flexible element can be inserted beyond that point and is caused to be forced through an articulating valve. The valve of this disclosure features enhancements in its sealing ability and in some embodiments provides a differing level of frictional engagement with the filament upon insertion versus withdrawal. The infusion port of this invention also has design features which provide a relatively small distance between the surface of the skin and the position of the articulating catheter valve through which the introduced filament passes.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Drawing from US Patent 5180365
Implantable infusion device - US Patent 5180365 Drawing
Implantable infusion device
Inventor     Ensminger; William D. (2770 Parkridge Dr., Ann Arbor, MI 48103); Knol; James A. (1059 Hasper, Ann Arbor, MI 48103); Andrews; James C. (3568 River Pines, Ann Arbor, MI 48103)
Owner/Assignee    
Patent assignment
All assignments
Company News
Publication Date     January 19, 1993
Application Number     07/654,661
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     February 15, 1991
US Classification     604/288.03 604/175
Int'l Classification     A61H 011/00
Examiner     Yasko; John D.
Assistant Examiner    
Attorney/Law Firm     Harness, Dickey & Pierce
Address
Parent Case     CROSS REFERENCE TO RELATED APPLICATIONS This application is a continuation-in-part of application Ser. No. 487,541 filed on Mar. 1, 1990, now U.S. Pat. No. 5,057,084 and application Ser. No. 539,793 filed on Jun. 18, 1990, now U.S. Pat. No. 5,053,013 both having a title common with this application.
Priority Data    
USPTO Field of Search     604/167 604/175 604/93 604/244 604/283 604/256 604/280
Patent Tags     implantable infusion
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
3288137



[0 after 0 votes]
3565078



[0 after 0 votes]
3699956



[0 after 0 votes]
3402710



[0 after 0 votes]
4886501
Johnston
604/175
Dec,1989

[0 after 0 votes]
4857053
Dalton
604/288.02
Aug,1989

[0 after 0 votes]
4842591
Luther
604/537
Jun,1989

[0 after 0 votes]
4790826
Elftman
604/175
Dec,1988

[0 after 0 votes]
4781695
Dalton
604/175
Nov,1988

[0 after 0 votes]
4781693
Martinez
604/175
Nov,1988

[0 after 0 votes]
4781680
Redmond
604/288.02
Nov,1988

[0 after 0 votes]
4712583
Pelmulder
137/852
Dec,1987

[0 after 0 votes]
4710174
Moden
604/175
Dec,1987

[0 after 0 votes]
4710167
Lazorthes
604/288.02
Dec,1987

[0 after 0 votes]
4704103
Stober
604/175
Nov,1987

[0 after 0 votes]
4695273
Brown
604/173
Sep,1987

[0 after 0 votes]
4692146
Hilger
604/288.01
Sep,1987

[0 after 0 votes]
4682981
Suzuki
604/158
Jul,1987

[0 after 0 votes]
4673394
Fenton, Jr.
604/175
Jun,1987

[0 after 0 votes]
4650473
Bartholomew
604/174
Mar,1987

[0 after 0 votes]
4645495
Vaillancourt
604/180
Feb,1987

[0 after 0 votes]
4634422
Kantrowitz
604/539
Jan,1987

[0 after 0 votes]
4623329
Drobish
604/29
Nov,1986

[0 after 0 votes]
4581020
Mittleman
604/175
Apr,1986

[0 after 0 votes]
4578063
Inman
604/175
Mar,1986

[0 after 0 votes]
4578061
Lemelson
604/170.01
Mar,1986

[0 after 0 votes]
4569675
Prosl
604/175
Feb,1986

[0 after 0 votes]
4547194
Moorehead
604/523
Oct,1985

[0 after 0 votes]
4543088
Bootman
604/288.02
Sep,1985

[0 after 0 votes]
4491126
Cullor
604/540
Jan,1985

[0 after 0 votes]
4490137
Moukheibir
604/28
Dec,1984

[0 after 0 votes]
4464178
Dalton
604/174
Aug,1984

[0 after 0 votes]
4447237
Frisch
604/175
May,1984

[0 after 0 votes]
4430081
Timmermans
604/256
Feb,1984

[0 after 0 votes]
4425119
Berglund
604/175
Jan,1984

[0 after 0 votes]
4405320
Cracauer
604/175
Sep,1983

[0 after 0 votes]
4387879
Tauschinski
251/149.1
Jun,1983

[0 after 0 votes]
4256102
Monaco
604/175
Mar,1981

[0 after 0 votes]
4230109
Geiss
604/533
Oct,1980

[0 after 0 votes]
4190040
Schulte
128/899
Feb,1980

[0 after 0 votes]
4181132
Parks
607/106
Jan,1980

[0 after 0 votes]
4810241
Rogers
604/28
Dec,1969

[0 after 0 votes]
4439188
Dennehey
604/534
Dec,1969

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B

[0 market size comments]
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 market share comments]
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 reasonable royalty comments]
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

[0 Guesstimation of Royalty Value Comments]
License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 license availability comments]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 owner/assignee comments]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

[0 competitive advantage comments]
Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

[0 commercial alternatives comments]
 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


We claim:

1. An implantable infusion port for allowing the introduction of a flexible filament such as a catheter wire or optical fiber into a patient and being accessed using a needle which penetrates the patient's skin with said filament being introduced into the port by said needle, comprising:

housing means defining an enlarged generally funnel shaped entrance orifice, with the surface of said entrance orifice formed of a hard material to guide said needle contacting said orifice to a focus area,

mounting means for fastening said port subcutaneously, an entrance passageway formed by said housing means extending from said focus area to a valve chamber and to an exit passageway communicating with a site within the patient,

valve means within said valve chamber for permitting said filament to pass through said valve means while restricting the flow of fluids across said valve means when said filament is removed, and

stop means within said entrance passageway between said focus area and said valve chamber for restricting the passage of said needle while permitting said flexible filament to pass through said entrance passageway and engage said valve means.

2. An implantable infusion port according to claim 1 wherein said stop means comprises a bend in said entrance passageway.

3. An implantable infusion port according to claim 1 wherein said entrance orifice defines a surface having a first included cone angle adjacent the outside perimeter of said entrance orifice and defining a second included cone angle adjacent said focus area which is smaller than said first included cone angle.

4. An implantable infusion port according to claim 3 wherein said first and second included cone angles are formed by joined conical surfaces.

5. An implantable infusion port according to claim 1 wherein said housing means entrance orifice has a central axis generally perpendicular to the patient's skin and further defines a projection which can be detected by external palpation after said port is implanted which indicates the orientation of said port.

6. An implantable infusion port according to claim 1 wherein said valve means comprises an articulating catheter valve.

7. An implantable infusion port according to claim 6 wherein said articulating catheter valve includes at least two leaflet valve elements each defining multiple leaves stacked together with at least one of said leaflet valve elements having three or more leaves with said leaves of each of said leaflet valve elements oriented such that said leaves are disaligned to enhance sealing of said valve.

8. An implantable infusion port according to claim 7 further comprising at least one ring valve element placed on one said of said leaflet valve elements.

9. An implantable infusion port according to claim 8 wherein said ring valve element is positioned on the side of said leaflet valve elements confronting said exit passageway.

10. An implantable infusion port according to claim 8 wherein said ring valve element is positioned on the side of said leaflet valve elements confronting said entrance orifice focus area.

11. An implantable infusion port according to claim 8 further comprising a spacer ring placed between said leaflet valve elements and said ring valve element.

12. An implantable infusion port according to claim 1 wherein said valve means imposes less friction upon said filament being inserted through said valve means than imposed upon said filament upon withdrawal of said filament.

13. An implantable infusion port for allowing the introduction of a flexible filament such as a catheter wire or optical fiber into a patient and being accessed using a needle which penetrates the patient's skin with said filament being introduced into the port by said needle, comprising:

a housing having a generally funnel shaped entrance orifice having a focus area and defining a surface having a first included cone angle around the outer perimeter of said entrance orifice and defining a second included cone angle adjacent said focus area smaller than said first included cone angle, said surface of said entrance orifice being formed of a hard material enabling said needle upon contacting said entrance orifice to be guided toward said focus area, and

means for mounting said port subcutaneously.

14. An implantable infusion port according to claim 13 wherein said first and second included cone angles are defined by joined conical surfaces.

15. An implantable infusion port according to claim 13 further comprising an articulating catheter valve within said housing for permitting said filament to pass into an entrance passageway and through said valve and to an exit passageway while restricting the flow of fluids across said valve when said filament is removed from said port.

16. An implantable infusion port according to claim 15 wherein said housing further defines stop means within said entrance passageway for restricting said needle from engaging said articulating catheter valve.

17. An implantable infusion port according to claim 16 wherein said stop means comprises a bend in said entrance passageway.

18. An implantable infusion port according to claim 13 wherein said housing entrance orifice has a central axis generally perpendicular to the patient's skin and further defines a projection which can be detected by external palpation after said port is implanted which indicates the orientation of said port.

19. An implantable infusion port according to claim 15 wherein said articulating catheter valve includes at least two leaflet valve elements each defining multiple leaves stacked together with at least one of said leaflet valve elements having three or more leaves with said leaves of each of said leaflet valve elements oriented such that they are disaligned to enhance sealing of said valve.

20. An implantable infusion port according to claim 19 further comprising at least one ring valve element placed on one side of said leaflet valve elements.

21. An implantable infusion port according to claim 19 further comprising a ring valve element positioned on the side of said leaflet valve elements confronting said exit passageway.

22. An implantable infusion port according to claim 20 wherein said ring valve element is positioned on the side of said leaflet valve elements confronting said entrance orifice focus area.

23. An implantable infusion port according to claim 20 further comprising a spacer ring placed between said leaflet valve elements and said ring valve element.

24. An implantable infusion port according to claim 15 wherein said valve imposes less friction upon said filament being inserted through said valve than imposed upon said filament upon withdrawal of said filament.

25. An implantable infusion port for allowing the introduction of a flexible filament such as a catheter wire or optical fiber into a patient and being accessed using a needle which penetrates the patient's skin with said filament being introduced into the port by said needle, comprising:

a housing defining a generally funnel shaped entrance orifice leading to a focus area,

an entrance passageway formed by said housing extending from said focus area to a valve chamber and to an exit passageway communicating with a preselected site within the patient,

a valve installed within said valve chamber for permitting the passage of said filament while resisting the flow of fluids across said valve when said filament is removed from said port,